Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Macular Abnormalities Associated With 5α-Reductase Inhibitor

Macular Abnormalities Associated With 5α-Reductase Inhibitor This case-control study assesses the association between macular abnormalities over time and the use of 5α-reductase inhibitors for treatment of benign prostatic hypertrophy and/or alopecia. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Macular Abnormalities Associated With 5α-Reductase Inhibitor

Loading next page...
 
/lp/american-medical-association/macular-abnormalities-associated-with-5-reductase-inhibitor-BY3sZMZ7Rw

References (46)

Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/jamaophthalmol.2020.1279
Publisher site
See Article on Publisher Site

Abstract

This case-control study assesses the association between macular abnormalities over time and the use of 5α-reductase inhibitors for treatment of benign prostatic hypertrophy and/or alopecia.

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Jul 7, 2020

There are no references for this article.